GlassScriptPhysician profile
Deepak Kademani
NPI 1356327431
$2,405.25
in general payments reported to CMS, 2019-2025
9 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Oral & Maxillofacial Surgery provider received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $238 · 2021: $149 · 2022: $376 · 2023: $519 · 2024: $426 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $948.60 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $340.96 | 2020-2021 | |
| Kls-Martin L.P. | $303.26 | 2019-2023 | |
| Biohorizons Implant Systems INC. | $233.14 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Straumann USA LLC | $215.51 | 2022 | |
| Align Technology, INC. | $171.26 | 2024 | Invisalign |
| Stryker Corporation | $145.63 | 2023-2025 | Na |
| Nobel Biocare USA | $34.55 | 2020 | |
| Benco Dental Supply Co. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Kademani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.